Latest News and Press Releases

– Ended the quarter with $46.6 million in cash, expected to fund operations into 2025 – Continued efforts to accelerate recruitment for DETECT trial Actively seeking alternate development and...

Achieved net revenues of $2.8 million for ZORYVE® (roflumilast) cream 0.3% in the first quarter of 2023, with unit demand growth nearly doubling quarter-over-quarterContinued expansion of commercial...

NASHVILLE, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced...

Demonstrates Strong Revenue Growth of 15% Year-over-Year and Increased Profitability with GAAP Operating Income of $7 Million and Adjusted EBITDA of $8.4 MillionCompany Raises its GAAP Operating...

VANCOUVER, British Columbia, May 08, 2023 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to announce its operating and financial results for the three...

Conference call and webcast today at 4:30 p.m. ET LOS ANGELES, May 08, 2023 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”) today...

BURLINGTON, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...

Fokus im Bereich der COVID-19-Impfstoffe liegt auf Vorbereitungen für eine Impfstoffanpassung vor der Herbstsaison sowie der Entwicklung von Impfstoffkandidaten und -kombinationen der nächsten...

COVID-19 vaccine franchise focused on vaccine adaptation readiness ahead of the fall season and advancing next generation vaccine candidates and combinationsBioNTech and partner OncoC4 plan to start a...

Atlantica Reports First Quarter 2023 Financial Results Revenue for the first quarter of 2023 reached $242.5 million, a 1.5% increase year-over-year on a comparable basis1 and a 2.0% decrease...